Inventor

MACCOSS MALCOLM

US118 patents

⚠️ This page may combine multiple inventors who share the name “MACCOSS MALCOLM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MACCOSS MALCOLM

MERCK & CO INC

Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Morpholine and thiomorpholine tachykinin receptor antagonists

Morpholine compounds are prodrugs useful as tachykinin receptor antagonists

C-purine nucleoside analogs as inhibitors of RNA-dependent RNA viral polymerase

Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase

Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virus

Hexahydro-5-imino-1,4-1,4-thiazepine derivatives as inhibitors of nitric oxide synthases

Pyrrolidine and piperidine modulators of chemokine receptor activity

Spiro-substituted azacycles as modulators of chemokine receptor activity

3,3-disubstituted piperidines as modulators of chemokine receptor activity

Morpholine compounds are prodrugs useful as tachykinin receptor antagonists

Treatment of migraine with morpholine tachykinin receptor antagonists

Process for preparing morpholine tachykinin receptor antagonists

Treatment of emesis with morpholine tachykinin receptor antagonists

Alicyclic compounds as tachykinin receptor antagonists

N,N-diacylpiperazines

Substituted azetidinones as anti-inflammatory and antidegenerative agents

Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents

N-alkylguanine acyclonucleosides as antiviral agents

Ribonucleoside cyclic acetal derivatives for the treatment of RNA-dependent RNA viral infection

Spiro-substituted azacycles as modulators of chemokine receptor activity

Peptidyl derivatives as inhibitors of interleukin-1β converting enzyme

Substituted β-alanine derivatives as cell adhesion inhibitors

Spiro-substituted azacycles as neurokinin antagonists

Cycloalkyl tachykinin receptor antagonists

Morpholine and thiomorpholine tachykinin receptor antagonists

Morpholine and thiomorpholine tachykinin receptor antagonists

Phenyl spiroethercycloalkyl tachykinin receptor antagonists

Substituted pyrazolopyrimidines as angiotensin II antagonists

Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Cyclopentyl modulators of chemokine receptor activity

Pyrrolidine modulators of chemokine receptor activity

Biarylalkanoic acids as cell adhesion inhibitors

Pyrrolidine modulators of chemokine receptor activity

Sulfonamides as cell adhesion inhibitors

Cyclic amine modulators of chemokine receptor activity

Cyclic amine modulations of chemokine receptor activity

Spiro-substituted azacycles as tachykinin receptor antagonists

Trypthophan ureas as neurokinnin antagonists

Substituted aryl piperazines as neurokinin antagonists

Peptidyl derivatives as inhibitors of interleukin-1β converting enzyme

N,N-diacylpiperazine tachykinin antagonists

Substituted pyrimidines, pyrimidinones and pyridopyrimidines

Nucleoside antiviral and anti-inflammatory compounds and compositions and methods for using same

Piperazinylalkylpyrimidines as hypoglycemic agents

Regioselective synthesis of 9-substituted purine acyclonucleoside derivatives

Cyclopentyl modulators of chemokine receptor activity

ISIS PHARMACEUTICALS INC

Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase

MERCK SHARP & DOHME

Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection

US ENERGY

Prodrugs based on phospholipid-nucleoside conjugates